Newsletter | January 12, 2022

01.12.22 -- How AstraZeneca Optimized Vapor Phase Hydrogen Peroxide Gassing Cycle Development With Enzyme Indicators

Featured Editorial
Industry Insights
The Challenges Of Moving A Bioconjugate From Clinic To Market

Working with a partner that provides a one-stop shop for bioconjugate development and manufacturing helps prevent missteps that threaten delivery of life-saving drugs to patients who need them.

Single-Use Manufacturing Systems: Implementation Considerations

As single-use systems continue to evolve, more biopharma companies will be able to benefit from their ever-improving reliability and unique adaptability as part of both fully single-use and hybrid processes. 

Enabling Perfusion Processes With Cell Retention Technologies

In this white paper, we explore various strategies for the intensification of upstream perfusion processes with cell retention technologies and the viability of each solution.

5 Ways Your Viral Vector Manufacturing Partner Should Make You Feel

Whether you’re choosing a new CDMO or evaluating a current one, it can feel easier to assess the rational elements than it is to consider areas such as everyday communications. 

How To Secure A Sustainable Supply Of Raw Materials

How can pharma companies secure the supply of vital APIs and intermediates and maintain consistent manufacturing costs? These steps minimize supply chain insecurity in a rapidly changing market.

Impact Of Scalable Freeze/Thaw Cycling On Protein Stability And Structure

The need for low-temperature storage capable of surmounting the molecular and logistical challenges associated with these treatments has become core to achieving commercial-scale production.

A Tale Of Two CDMOs: Which Choice Will Your Biopharma Make?

Today’s growing biologics challenges make the choice of a CDMO critical. You need a trusted and experienced partner from DNA sequence to commercial launch and at each checkpoint along the way.

Controlling Host Cell Proteins In Drug Development
Explore methods to detect host cell proteins (HCPs) and how to reduce the risk of unexpected HCPs and maximize the efficiency of your HCP management strategy.
Quality By Design Principles For Analytical Methods

A quality by design (QbD) approach was used to solve a high-performance liquid chromatography analytical method problem where impurity peaks had shifting retention times, making identification and quantitation problematic.

Emerging Process Analytical Technology (PAT): Light Induced Fluorescence Sensing

In this application note we review an established photometric light-induced fluorescence sensor that has been applied to routine process monitoring and control GMP applications.

Collaborating Strategically And Leveraging Innovation To Drive Success

Senior vice president for business development Federico Pollano explains how his company is leveraging its 50-year experience and dual sites in Germany and the United States to flexibly meet market demand.

Development, Manufacture Of Biologics Produced In Microbial Systems

We discuss the trends in new molecular formats, which is one of the current drivers of renewed interest in fermentation technologies, along with some of their challenges. 

Accelerate The Development And Production Of Viral-Based Gene Therapies

The pandemic revealed that with the proper framework a drug product can be developed, clinically tested, and produced for hundreds of millions of patients in less than a year. 

Rapid Cell Culture Media Analysis For C> Process Development

This webinar discusses how to accelerate process analytics with fast nutrient screening at critical timepoints and the benefits of rapid media analysis in cell therapy development and viral vector production. 

Life Science Leader Magazine

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.